Lipid abnormalities in uremia, dialysis, and transplantation (Q40316755)

19 September 2017

1 reference

title

Lipid abnormalities in uremia, dialysis, and transplantation (English)

1 reference

19 September 2017

0 references

1 reference

Chan MK

1

1 reference

19 September 2017

Varghese Z

series ordinal

2

1 reference

19 September 2017

Moorhead JF

series ordinal

3

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 May 1981

1 reference

19 September 2017

1 reference

19 September 2017

19

1 reference

19 September 2017

5

1 reference

19 September 2017

625-637

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1981.62

19 September 2017

0 references

cites work

Hypertriglyceridemia. A metabolic consequence of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Plasma lipoprotein patterns in patients receiving dialysis therapy for chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Dietary treatment of hyperlipidemia in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Hyperlipidaemia after successful renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Accelerated atherosclerosis in prolonged maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Deaths from Occlusive Arterial Disease in Renal Allograft Recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Hyperlipoproteinemia in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Prevalence of serum lipid abnormalities in chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Lipoprotein spectrum analysis of uremic patients maintained on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Lipid and carbohydrate metabolism in uraemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Application of a new intravenous fat tolerance test in the study of hypertriglyceridaemia in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Intravenous fat tolerance Correlation with very low density lipoprotein apoprotein b kinetics in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Metabolic Fate of Chylomicron Phospholipids and Apoproteins in the Rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Hypertriglyceridemia in chronic nonnephrotic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Selective Deficiency of Hepatic Triglyceride Lipase in Uremic Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Hepatic and extrahepatic triglyceride lipase activity in uraemic patients on chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Heparin-Released Plasma Lipases in Chronic Renal Failure and after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Postheparin plasma triglyceride lipases in chronic hemodialysis: Evidence for a role for hepatic lipase in lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on Hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Effect of Fasting on Two Postheparin Plasma Triglyceride Lipases and Triglyceride Removal in Obese Subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Availability of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Apoprotein composition of plasma lipoproteins in uremic patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-II

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III-2

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Apolipoprotein A-I synthesis and secretion by cultured human intestinal mucosa

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Plasma triglyceride metabolism in thyroid disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Thyroid function and lipids in patients with chronic renal disease treated by hemodialysis: With comments on the “free thyroxine index”

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Lipids and Lipoproteins in Chronic Uraemia. A Study of the Influence of Regular Haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Glucagon resistance as a hormonal basis for endogenous hyperlipaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Plasma lipids in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Reappraisal of the role of insulin in hypertriglyceridemia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Lipoprotein lipase activity of human adipose tissue in health and in some diseases with hyperlipidemia as a common feature

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Adipose Tissue Lipoprotein Lipase in Chronic Hemodialysis: Role in Plasma Triglyceride Metabolism*

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Growth Hormone in Uremia I. Plasma Growth Hormone, Insulin and Glucagon after Oral and Intravenous Glucose in Uremic Subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Regulation of endogenous plasma triglyceride concentration: can we measure the rate of production or of removal of endogenous plasma triglycerides in man?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Plasma triglyceride secretion and metabolism in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Reduction of plasma triglycerides by diet in subjects with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Triglyceride turnover in severe chronic non-nephrotic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Polymorphism of plasma triglyceride kinetics in normal human adult subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

The effect of uremia and kidney transplantation on the binding capacity of albumin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

DIETARY SUGAR IN THE PRODUCTION OF HYPERGLYCERIDEMIA

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Treatment of hyperlipidaemia in patients on chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Triglyceride clearance during diets rich in carbohydrate or fats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Carnitine deficiency induced during intermittent haemodialysis for renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Action of carnitine on long chain fatty acid oxidation by liver

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Carnitine and trimethylaminobutyrate synthesis in rat tissues

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Evaluation of Amino Acid and Protein Requirements in Chronic Uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Tissue Carnitine Deficiency due to Dietary Lysine Deficiency: Triglyceride Accumulation and Concomitant Impairment in Fatty Acid Oxidation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Myasthenia-like syndrome associated with carnitine in patients on long-term haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Hypolipaemic effect of carnitine in uraemic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Long-term heparin infusion and plasma lipoprotein lipase activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Hypertriglyceridemia in patients with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Fat clearance before and after heparin in chronic renal failure--haemodialysis reduces post-heparin fractional clearance rates of intralipid

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

A protein cofactor of lecithin:cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Circulating Lipoproteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

High density lipoproteins reduce the uptake of low density lipoproteins by human endothelial cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

High density lipoprotein cholesterol and coronary artery occlusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Elevation of serum lipid levels during diuretic therapy of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Effect of chronic administration of propranolol on lipoprotein composition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Glucocorticoids and triglyceride transport: Effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Lipid Disorders in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Modulation of the Activity of Insulin-Dependent Enzymes of Lipogenesis by Glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Decreased Insulin Binding to Lymphocytes from Diabetic Subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1981.62

7 January 2021

Identifiers

DOI

10.1038/KI.1981.62

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference